Brad Thomas

Brad Thomas is a Global Medical Affairs Leader with a robust background in precision medicine and a commitment to improving patient health. They earned a PhD from the University of Calgary, focusing on bacteriophage as a chimeric vaccine scaffold and conducted postdoctoral research on hepatitis C at the University of Alberta. At AstraZeneca, they currently identify patients through testing pathways while previously achieving significant growth in territory as a Molecular Account Executive at Abbott. Brad's expertise spans various fields, including molecular biology, virology, and project management, complemented by a strong track record in consultative selling and building effective partnerships.